All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.
Martin S. Tallman;Janet W. Andersen;Charles A. Schiffer;Frederick R. Appelbaum.
Transfusion-associated graft-versus-host disease.
Anderson Kc;Weinstein Hj.
The New England Journal of Medicine (1990)
Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821.
S C Raimondi;M N Chang;Y Ravindranath;F G Behm.
Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update
Howard J. Weinstein;Robert J. Mayer;David S. Rosenthal;Felice S. Coral.
Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome.
Charles Peters;Michael Balthazor;Elsa G. Shapiro;Roberta J. King.
Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood
Ravindranath Y;Yeager Am;Chang Mn;Steuber Cp.
The New England Journal of Medicine (1996)
A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481.
Gita V. Massey;Alvin Zipursky;Myron N. Chang;John J. Doyle.
Treatment of Acute Myelogenous Leukemia in Children and Adults
Howard J. Weinstein;Robert J. Mayer;David S. Rosenthal;Bruce M. Camitta.
The New England Journal of Medicine (1980)
Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease.
George R. Siber;Sigmund A. Weitzman;Alan C. Aisenberg;Howard J. Weinstein.
The New England Journal of Medicine (1978)
Surface marker analysis of acute myeloblastic leukemia: identification of differentiation-associated phenotypes.
James D. Griffin;Robert J. Mayer;Howard J. Weinstein;David S. Rosenthal.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: